APA (7th ed.) Citation

Lapinskas, T., Klein, C., Pedrizzetti, G., Stoiber, L., Hennig, F., Knosalla, C., . . . Kelle, S. (2018). Abstract 16628: Improvement of LV-Strain in HFrEF-Patients at 12 Months Follow-Up Using the Revivent TM System (Bioventrix) Compared to Patients Treated by OMT- Results From a CMR-Multi-Center-Trial. Circulation (New York, N.Y.), 138(Suppl_1 Suppl 1), A16628. https://doi.org/10.1161/circ.138.suppl_1.16628

Chicago Style (17th ed.) Citation

Lapinskas, Tomas, et al. "Abstract 16628: Improvement of LV-Strain in HFrEF-Patients at 12 Months Follow-Up Using the Revivent TM System (Bioventrix) Compared to Patients Treated by OMT- Results From a CMR-Multi-Center-Trial." Circulation (New York, N.Y.) 138, no. Suppl_1 Suppl 1 (2018): A16628. https://doi.org/10.1161/circ.138.suppl_1.16628.

MLA (9th ed.) Citation

Lapinskas, Tomas, et al. "Abstract 16628: Improvement of LV-Strain in HFrEF-Patients at 12 Months Follow-Up Using the Revivent TM System (Bioventrix) Compared to Patients Treated by OMT- Results From a CMR-Multi-Center-Trial." Circulation (New York, N.Y.), vol. 138, no. Suppl_1 Suppl 1, 2018, p. A16628, https://doi.org/10.1161/circ.138.suppl_1.16628.